Low-dose metformin in the brain: A focused review of its novel mechanism of glucose lowering in type 2 diabetes
{{output}}
Metformin remains the first-line pharmacological therapy for type 2 diabetes mellitus (T2DM). While its glucose-lowering effects have primarily been attributed to peripheral actions, evidence indicates that it also crosses the blood-brain barrier (BBB) and can... ...
